UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000011295
Receipt number R000013234
Scientific Title Analysis of the interaction between Remifentanyl and Desflurane, Comparison of autonomic nervous responses, heart rate variability and entropy, to nociceptive stimuli.
Date of disclosure of the study information 2013/08/01
Last modified on 2013/07/27 04:17:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Analysis of the interaction between Remifentanyl and Desflurane, Comparison of autonomic nervous responses, heart rate variability and entropy, to nociceptive stimuli.

Acronym

Analysis of the interaction between Remifentanyl and Desflurane.

Scientific Title

Analysis of the interaction between Remifentanyl and Desflurane, Comparison of autonomic nervous responses, heart rate variability and entropy, to nociceptive stimuli.

Scientific Title:Acronym

Analysis of the interaction between Remifentanyl and Desflurane.

Region

Japan


Condition

Condition

General surgery

Classification by specialty

Anesthesiology Operative medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We conducted a study to investigate evaluate MAC-BAR (minimum alveolar concentration, blockade of Autonomic Response) of Desflurane was potentiated by Remifentanyl by using the device for monitoring Heart Rate Variability and Entropy.

Basic objectives2

Bio-equivalence

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase



Assessment

Primary outcomes

Decrement MAC BAR of Desflurane by Remifentanyl.

Key secondary outcomes

Limited role of Desflurane inhalation on Decrement MAC BAR.


Base

Study type


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Cluster

Blinding

Single blind -participants are blinded

Control

Dose comparison

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment

Pseudo-randomization


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

injection dose of remifentanyl

Interventions/Control_2

inhalation dose of desflurane

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

ASA physical status I-II,
aged 20&#8211;70years,
scheduled for elective Laparoscopic Gallbladder surgery (Cholecystectomy)
expected to last at least 5 h

were enrolled in this prospective,
single-blinded, randomized trial.

Key exclusion criteria

Patients with a history
of arhythmia, chronic use of psychoactivemedication or illicit drugs, and any clinical significant
cardiovascular, renal, hepatic, or endocrinologic disorders
were excluded.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Ayano Ooiwa

Organization

Toho University School of Medicine

Division name

Depertment of Anesthesiology

Zip code


Address

6-11-1 Omori-Nishi Ota-ku, Tokyo 143-8541, Japan

TEL

03-3762-4151

Email



Public contact

Name of contact person

1st name
Middle name
Last name Ayano Ooiwa

Organization

Toho University School of Medicine

Division name

Depertment of Anesthesiology

Zip code


Address

6-11-1 Omori-Nishi Ota-ku, Tokyo 143-8541, Japan

TEL

03-3762-4151

Homepage URL


Email

Ayano-nakao@leaf.ocn.ne.jp


Sponsor or person

Institute

Toho University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Toho University School of Medicine

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東邦大学医療センター大森病院


Other administrative information

Date of disclosure of the study information

2013 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2013 Year 03 Month 08 Day

Date of IRB


Anticipated trial start date

2013 Year 04 Month 01 Day

Last follow-up date

2015 Year 04 Month 01 Day

Date of closure to data entry

2015 Year 10 Month 01 Day

Date trial data considered complete

2016 Year 04 Month 01 Day

Date analysis concluded

2016 Year 04 Month 01 Day


Other

Other related information



Management information

Registered date

2013 Year 07 Month 27 Day

Last modified on

2013 Year 07 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013234


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name